Absence of dendritic reticulum cell staining is helpful for distinguishing T-cell-rich B-cell lymphoma from lymphocyte predominance Hodgkin's disease

Applied Immunohistochemistry

Volumn 6, Issue 1, 1998, Pages 16-22

  Fleming, Mark D ^a   Shahsafaei, Aliakbar ^a   Dorfman, David M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD21; Low affinity nerve growth factor receptor; Non Hodgkin's lymphoma

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER CLASSIFICATION; CLINICAL ARTICLE; DENDRITE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RETICULUM CELL; RUMINANT STOMACH; T CELL LYMPHOMA; T LYMPHOCYTE;

EID: 0031921567     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199803000-00004     Document Type: Article

References (23)

1. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988; 12: 433-43.
2. Ng CS, Chan JKC, Hui PK, Lau WH. Large B-cell lymphomas with a high content of reactive T cells. Hum Pathol 1989;20:1145-54.
3. Chittal SM, Brousset P, Voigt J-J, Delsol G. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology 1991;19:211-20.
4. Macon WR, Williams ME, Greer JP, Stein RS, Collins RD, Cousar JB. T-cell-rich B-cell lymphomas: a clinicopathologic study of 19 cases. Am J Surg Pathol 1992;16:351-63.
5. Rodriguez J, Pugh WC, Cabanillas F. T-cell-rich B-cell lymphoma. Blood 1993;82:1586-9.
6. Krishnan J, Wallberg K, Frizzera G. T-cell-rich B-cell lymphoma: a study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 1994;18:455-65.
7. Warnke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Tumors of the lymph nodes and spleen. Atlas of tumor pathology, third series, fascicle 14, Washington, DC: Armed Forces Institute of Pathology, 1995.
8. Pinkus GS, Said JW. Hodgkin's disease, lymphocyte predominance type, nodular - further evidence for a B cell derivation: L&H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol 1988;133:211-7.
9. Schmidt U, Herbst J, Metz KA, Leder L-D. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte predominance Hodgkin's disease: evidence for the value of MB1 and 4KB5 immunostaining. J Pathol 1996;179:138-44.
10. Naiem M, Gerdes J, Abdulaziz Z, et al. Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. J Clin Pathol 1983;36:167-75.
11. Abdulaziz Z, Mason DY, Stein H, Gatter KC, Nash JRG. An immunohistochemical study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel. Histopathology 1984;8:1-25.
12. Dorfman DM, Shahsafaei A. Dendritic reticulum cell immunore-activity for low affinity nerve growth factor receptor in malignant lymphomas. Mod Pathol 1996;10:959-65.
13. Timens W, Visser L, Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Lab Invest 1986;54:457-61.
14. Poppema S. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol 1989;135:351-7.
15. Kamel OW, Gelb AB, Shibuya RB, Warnke RA. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Am J Pathol 1993; 142:541-6.
16. Cattoretti G, Schiro R, Orazi A, et al. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cell in vivo and in vitro. Blood 1993;81:1726-38.
17. Delabie J, Vandenberghe E, Kennes C, et al. Histiocyte-rich B-cell lymphoma: a distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma sub-type. Am J Surg Pathol 1992;16:37-48.
18. Hsu SM, Ho YS, Li PJ, et al. L&H variants of Reed-Sternberg cells express sialylated Leu Ml antigen. Am J Pathol 1986;122:199-203.
19. Schwarting R, Gerdes J, Durkop H, et al. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989;74:1678-89.
20. Said JW, Sassoon AF, Shintaku IP, Kurtin PJ, Pinkus GS. Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease: results of Southern blot analysis and polymerase chain reaction. Am J Pathol 1991; 138:261-4.
21. Cattoretti G, Pileri S, Parravicini C, et al. Antigen unmasking on formalin-fixed paraffin-embedded tissue sections. J Pathol 1993; 171:83-98.
22. Gown AM, de Wever N, Battifora H. Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993;1:256-66.
23. Leong AS-Y, Milios J. An assessment of the efficacy of the microwave antigen-retrieval procedure on a range of tissue antigens. Appl Immunohistochem 1993;1:267-74.